Medtronic always seeks the best available information technology solutions — open-sourced or closed-source — to serve our customers and patients. All software/firmware that resides in Medtronic devices and associated instrumentation is reviewed, approved and regulated by the FDA.
Software/firmware that runs on Medtronic devices is highly specialized to both our application as well as our unique, custom hardware platforms; to that end, it is not likely that a patient would see value in viewing software for our platforms. Furthermore,
enabling a patient to view a program code for Medtronic’s devices would require full disclosure of our proprietary hardware platforms and implementations. Security protocols and mechanisms leveraged by Medtronic’s devices and associated instrumentation
are public and standardized; Medtronic has not created unique security mechanisms or protocols for our systems.
It is important to note that sudden cardiac arrest kills 95 percent of the people who experience it within minutes. The only effective treatment for sudden cardiac arrest is defibrillation. Defibrillators are 98 percent effective in terminating life threatening arrhythmias that lead to sudden cardiac arrest.